Expression of transforming growth factor β₁ in mesenchymal stem cells: Potential utility in molecular tissue engineering for osteochondral repair

Abstract

The feasibility of using gene therapy to treat full-thickness articular cartilage defects was investigated with respect to the transfection and expression of exogenous transforming growth factor (TGF)-β₁ genes in bone marrow-derived mesenchymal stem cells (MSCs)in vitro. The full-length rat TGF-β₁ cDNA was transfected to MSCs mediated by lipofectamine and then selected with G418, a synthetic neomycin analog. The transient and stable expression of TGF-β₁ by MSCs was detected by using immunohistochemical staining. The lipofectamine-mediated gene therapy efficiently transfected MSCsin vitro with the TGF-β₁ gene causing a marked up-regulation in TGF-β₁ expression as compared with the vector-transfected control groups, and the increased expression persisted for at least 4 weeks after selected with G418. It was suggested that bone marrow-derived MSCs were susceptible toin vitro lipofectamine mediated TGF-β₁ gene transfer and that transgene expression persisted for at least 4 weeks. Having successfully combined the existing techniques of tissue engineering with the novel possibilities offered by modern gene transfer technology, an innovative concept, i.e. molecular tissue engineering, are put forward for the first time. As a new branch of tissue engineering, it represents both a new area and an important trend in research. Using this technique, we have a new powerful tool with which: (1) to modify the functional biology of articular tissue repair along defined pathways of growth and differentiation and (2) to affect a better repair of full-thickness articular cartilage defects that occur as a result of injury and osteoarthritis.

Keywords

artieular cartilage defect repair / tissue engineering / gene transfer / molecular tissue engineering / transforming growth factor β₁ / mesenchymal stem cells

References

[1] GrandeD, BreitbartA, MasonJ, et al. . Cartilage tissue engineering: current limitations and solutions. Clin Orthop, 1999, 367SS176-S176

[2] BrittbergM, LindahlA, NilssonA, et al. . Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med, 1994, 331889-889

[3] ReddiA. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng, 2000, 6(4): 351-351

[4] FreedL, MartinI, Vunjak-NovakovicG. Frontiers in tissue engineering: in vitro modulation of chondrogenesis. Clin Orthop, 1999, 367SS46-S46

[5] EvansC, GhivizzaniS, SmithP, et al. . Using gene therapy to protect and restore cartilage. Clin Orthop, 2000, 379 SupplS214-S214

[6] FernandesJ, Martel-PelletierJ, PelletierJ. Gene therapy for osteoarthritis: new perspectives for the twenty-first century. Clin Orthop, 2000, 379 SupplS262-S262

[7] MasonJ M, BreitbartA S, BarciaM, et al. . Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin Orthop, 2000, 379 SupplS171-S171

[8] GuoX D, DuJ Y, ZhengQ X, et al. . Molecular tissue engineering: applications for modulation of mesenchymal stem cells proliferation by transforming growth factorβ₁ gene transfer. J Tongji Med Univ, 2001, 21(4): 177-177

[9] LiuY, ZhengQ X, DuJ Y, et al. . Cloning and expression of rat transforming growth factorβ₁ cDNA in osteoblasts. J Tongji Med Univ, 2000, 20(1): 63-63

[10] JohnstoneB, YooJ. Autologous mesenchymal progenitol cells in articular cartilage repair. Clin Orthop, 1999, 367SS156-S156

[11] YooJ, MandellI, AngeleP, et al. . Chondrogenitor cells and gene therapy. Clin Orthop, 2000, 379 SupplS164-S164

[12] CaplanA I. Mesenchymal stem cells and gene therapy. Clin Orthop, 2000, 379 SupplS67-S67

[13] AraiY, KuboT, KobayashiK, et al. . Adenovirus vectormediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-β₁ and heat shock protein 70 gene transduction. J Rheumatol, 1997, 24(9): 1787-1787

[14] LlullR. Immune considerations in tissue engineering. Clin Plast Surg, 1999, 26(4): 549-549

[15] KangR, MaruiT, GhivizzaniS, et al. . Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis and Cartilage, 1997, 5139-139